Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study were designed to verify the better method of survival for ICC with distant
metastasis. Since the traditional method for ICC with distant metastasis. was
GEMOX(first-line treatment from NCCN guideline), our previous study found similar results
from FOLFOX (second-line treatment from NCCN guideline) compared with GEMOX.
Our current study were conducted for further investigation to verify the better method for
with distant metastasis.